rxstat › Drug prices › Nimodipine

Nimodipine (Nimotop) price in Canada

No current shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Nimodipine 30 mg tablet costs about $10.30 per tablet on public drug plan price lists across 4 provinces, before the pharmacy's dispensing fee.

Nimodipine has no current shortage reported in Canada. It has been in shortage before; the history is below.

Price by province

Strength and formABSKONNBNS
30 mg Tabletper tablet$10.30not covered$10.30$10.30$10.30$10.30
Plan coverageNot coveredCoveredCoveredCoveredCovered

Lowest price per unit among each province's covered products, with the brand price where it is notably higher. A dash means the province does not list it.

Detailed price and coverage in your province:

What you'll pay at the pharmacy

These are the prices public drug plans list for the drug itself. At the counter, pharmacies add a dispensing fee and in some provinces a markup, so paying cash costs more, and for cheap generics the fee is often more than the drug. If you have a public or private plan, your share depends on its deductible and co-pay.

Listed products by province

Alberta: 1 product
  • Nimotop 30 mg Tablet · LXO
    DIN 02325926 · $10.30/tablet · Not covered
Saskatchewan: 1 product
  • Nimotop 30 mg Tablet · LXO
    DIN 02325926 · $10.30/tablet · Covered
Ontario: 1 product
  • Nimotop 30 mg Tablet · Laboratoire X.O
    DIN 02325926 · $10.30/tablet · Covered
New Brunswick: 1 product
  • Nimotop 30 mg Tablet · LXO
    DIN 02325926 · $10.30/tablet · Covered
Nova Scotia: 1 product
  • Nimotop 30 mg Tablet · LXO
    DIN 02325926 · $10.30/tablet · Covered

Price sources: Ontario Drug Benefit Formulary (Oct 30, 2026) · Alberta Drug Benefit List and Alberta Blue Cross price list (Nov 1, 2026) · Saskatchewan Drug Plan Formulary (Nov 1, 2026) · New Brunswick Drug Plans Formulary (Nov 1, 2026) · Nova Scotia Pharmacare Formulary (Nov 1, 2026). Other provinces and territories will be added as their public price lists are brought in.

Shortage status

Products affected
0 / 1
Reports on file
4

Reports by product

The DIN is printed on your prescription label.

Avoided
NIMOTOP
30MG · TABLET · BAYER INC
DIN 02325926 · ended Mar 25, 2019 · Disruption of the manufacture of the drug.
Resolved
NIMOTOP
30MG · TABLET · BAYER INC
DIN 02325926 · ended Jan 24, 2019 · Disruption of the manufacture of the drug.
Resolved
NIMOTOP
30MG · TABLET · BAYER INC
DIN 02325926 · ended Oct 15, 2018 · Disruption of the manufacture of the drug.
Resolved
NIMOTOP
30MG · TABLET · BAYER INC
DIN 02325926 · ended Apr 25, 2018 · Delay in shipping of the drug.

What's happening

There are no active shortage reports for Nimodipine. Health Canada has 4 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

Nimodipine is classified under “SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.” (ATC C08CA).

Recent changes

Common questions

How much does Nimodipine cost in Canada?

Nimodipine 30 mg tablet costs about $10.30 per tablet on public drug plan price lists across 4 provinces, before the pharmacy's dispensing fee.

Is Nimodipine covered by provincial drug plans?

On the public plans' own lists: Alberta: not covered; Saskatchewan: covered; Ontario: covered; New Brunswick: covered; Nova Scotia: covered. "Special approval" means the plan covers it only for some patients, on a request from the prescriber. "Price list" means the province publishes its price but not its coverage.

When will Nimodipine be back in stock in Canada?

Nimodipine has no active shortage; supply is normal per Health Canada reports.

Why is Nimodipine in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs (selective calc.channel block. w/mainly vasc. eff.)

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.